APA (7th ed.) Citation

Velikova, T., Sekulovski, M., & Peshevska-Sekulovska, M. (2024). Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development. Antibodies (2073-4468), 13(1), 16. https://doi.org/10.3390/antib13010016

Chicago Style (17th ed.) Citation

Velikova, Tsvetelina, Metodija Sekulovski, and Monika Peshevska-Sekulovska. "Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development." Antibodies (2073-4468) 13, no. 1 (2024): 16. https://doi.org/10.3390/antib13010016.

MLA (9th ed.) Citation

Velikova, Tsvetelina, et al. "Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development." Antibodies (2073-4468), vol. 13, no. 1, 2024, p. 16, https://doi.org/10.3390/antib13010016.